|ACTIVITY ACCREDITATION INFORMATION
CVD and PCSK9 Inhibitors: Analyzing the Outcome Studies and Understanding Their ImplicationsACTIVITY FORMAT
Internet Enduring Material
FEE: There is no fee for this activity.
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management and CV disease risk reduction.
TYPE OF ACTIVITY
At the conclusion of this activity, all participants should be able to:
- Identify the need for effective therapies for patients with familial hypercholesterolemia
- Assess the efficacy and safety data for recent trials that examined the cardiovascular impact of PCSK9 inhibitors
- Evaluate patient groups in which treatment beyond statins may be needed to decrease lipid-related CV risk
- Discuss strategies to improve the knowledge, skills or performance of the healthcare team.
CRITERIA FOR SUCCESS
To participate in the activity, go to http://www.cardiocarelive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the posttest. If you have questions about this CME/CE activity, please contact the NLA at firstname.lastname@example.org. Please claim credit by November 23, 2017.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
This activity is supported by an educational grant from Amgen.
||Credit provided by the National Lipid Association
In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and PlatformQ Health Education, LLC. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation Statement
The National Lipid Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
The National Lipid Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Universal Activity Number 0624-0000-17-026-L01-P (Knowledge) The National Lipid Association designates this continuing education activity for 1.00 contact hour(s) (.10 CEUs) of the Accreditation Council for Pharmacy Education
This educational activity for 1 contact hour is provided by The National Lipid Association. The National Lipid Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Michael J. Blaha, MD, MPH
Director of Clinical Research, Ciccarone Center for the Prevention of Heart Disease; Assistant Professor of Medicine
Johns Hopkins University
Marc S. Sabatine, MD, MPH
Chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group;
Lewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine,
Brigham and Women’s Hospital;
Professor of Medicine,
Harvard Medical School
James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA, FASPC
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention;
Director, Bellevue Hospital Lipid Clinic;
President-Elect, National Lipid Association
|FACULTY/PLANNER/STAFF FINANCIAL DISCLOSURES
|FACULTY/PLANNER FINANCIAL DISCLOSURES
|Amgen, MedImmune, Novartis, Sanofi/Regeneron
Aetna Foundation, Amgen
|Amgen, AstraZeneca, Daiichi-Sankyo, Eisai, GlaxoSmithKline, Intarcia, Janssen Research Development, MedImmune, Merck & Co., Inc., Novartis, Pfizer, Poxel, Takeda
Amgen, CVS Caremark, Esperion, Intarcia, Ionis, MedImmune, Merck & Co., Inc.
|Akcea, Alexion, Amgen, Invitae, Regeneron, Sanofi
Alexion, Amarin, Amgen, Regeneron, Sanofi, True Health Diagnostics
|PlatformQ Health Education, LLC
||Nothing to Disclose
||Nothing to Disclose
|Sean D. Stewart, PharmD
||Nothing to Disclose
DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCT
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NLA prior to accreditation of the activity. NLA planners and reviewers have no relevant financial relationships to disclose.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.
ESTIMATED TIME TO COMPLETE
This activity consists of one session, which should take approximately 1 hour to complete.
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Please contact the National Lipid Association at email@example.com.
For any technical issues or issues with your CME Certificate, please contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com.